Literature DB >> 30826019

PET-Based Imaging of Ischemic Heart Disease.

Kevin Chen1, Edward J Miller1, Mehran M Sadeghi2.   

Abstract

PET-based cardiac nuclear imaging plays a large role in the management of ischemic heart disease. Compared with conventional single-photon emission CT myocardial perfusion imaging, PET provides superior accuracy in diagnosis of coronary artery disease and, with the incorporation of myocardial blood flow and coronary flow reserve, adds value in assessing prognosis for established coronary and microvascular disease. This review describes these and other uses of PET in ischemic heart disease, including assessing myocardial viability in ischemic cardiomyopathy. Developments in novel PET flow tracers and molecular imaging tools to assess atherosclerotic plaque vulnerability, vascular calcification, and vascular remodeling also are described. Published by Elsevier Inc.

Entities:  

Keywords:  Coronary artery disease; Coronary flow reserve; Molecular imaging; Myocardial perfusion imaging; Myocardial viability; PET/CTA hybrid imaging

Mesh：

Substances：

Year:  2019        PMID： 30826019      PMCID： PMC6426655          DOI： 10.1016/j.cpet.2018.12.003

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  57 in total

1.  What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography?

Authors:  Keiichiro Yoshinaga; Benjamin J W Chow; Kathryn Williams; Li Chen; Robert A deKemp; Linda Garrard; Alexander Lok-Tin Szeto; May Aung; Ross A Davies; Terrence D Ruddy; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2006-08-17       Impact factor: 24.094

2.  Quantitative (82)Rb PET/CT: development and validation of myocardial perfusion database.

Authors:  Cesar A Santana; Russell D Folks; Ernest V Garcia; Liudmila Verdes; Rupan Sanyal; Jon Hainer; Marcelo F Di Carli; Fabio P Esteves
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

3.  Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.

Authors:  Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 10.057

4.  Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events.

Authors:  Thomas H Schindler; Egbert U Nitzsche; Heinrich R Schelbert; Manfred Olschewski; James Sayre; Michael Mix; Ingo Brink; Xiao-Li Zhang; Michael Kreissl; Nobuhisa Magosaki; Hanjoerg Just; Ulrich Solzbach
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

5.  Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.

Authors:  Stefano Sdringola; Keiichi Nakagawa; Yuko Nakagawa; S Wamique Yusuf; Fernando Boccalandro; Nizar Mullani; Mary Haynie; Mary Jane Hess; K Lance Gould
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

6.  Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.

Authors:  Rob S B Beanlands; Terrence D Ruddy; Robert A deKemp; Robert M Iwanochko; Geoffrey Coates; Michael Freeman; Claude Nahmias; Paul Hendry; Robert J Burns; Andre Lamy; Lynda Mickleborough; William Kostuk; Ernest Fallen; Graham Nichol
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

7.  Coronary vasomotor abnormalities in insulin-resistant individuals.

Authors:  Manuel J Quiñones; Miguel Hernandez-Pampaloni; Heinrich Schelbert; Isabel Bulnes-Enriquez; Xochitl Jimenez; Gustavo Hernandez; Roxana De La Rosa; Yun Chon; Huiying Yang; Susanne B Nicholas; Tamara Modilevsky; Katherine Yu; Katja Van Herle; Lawrence W Castellani; Robert Elashoff; Willa A Hsueh
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

8.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT.

Authors:  Timothy M Bateman; Gary V Heller; A Iain McGhie; John D Friedman; James A Case; Jan R Bryngelson; Ginger K Hertenstein; Kelly L Moutray; Kimberly Reid; S James Cullom
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

9.  Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome.

Authors:  Nobuhiro Tahara; Hisashi Kai; Sho-ichi Yamagishi; Minori Mizoguchi; Hiroyuki Nakaura; Masatoshi Ishibashi; Hayato Kaida; Kenkichi Baba; Naofumi Hayabuchi; Tsutomu Imaizumi
Journal:  J Am Coll Cardiol       Date:  2007-03-26       Impact factor: 24.094

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690
View more
  3 in total

1.  Ischemic Heart Disease: Noninvasive Imaging Techniques and Findings.

Authors:  Arlene Sirajuddin; S Mojdeh Mirmomen; Seth J Kligerman; Daniel W Groves; Allen P Burke; Faraz Kureshi; Charles S White; Andrew E Arai
Journal:  Radiographics       Date:  2021-05-21       Impact factor: 6.312

2.  Intensive care unit management of percutaneous mechanical circulatory supported patients: the role of imaging.

Authors:  Andrea Montisci; Letizia F Bertoldi; Susanna Price; Christian Hassager; Jacob Møller; Federico Pappalardo
Journal:  Eur Heart J Suppl       Date:  2021-03-27       Impact factor: 1.803

Review 3.  Multimodality Imaging in Ischemic Chronic Cardiomyopathy.

Authors:  Giuseppe Muscogiuri; Marco Guglielmo; Alessandra Serra; Marco Gatti; Valentina Volpato; Uwe Joseph Schoepf; Luca Saba; Riccardo Cau; Riccardo Faletti; Liam J McGill; Carlo Nicola De Cecco; Gianluca Pontone; Serena Dell'Aversana; Sandro Sironi
Journal:  J Imaging       Date:  2022-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.